B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the Breathing Not Properly Multinational Study

American Journal of Kidney Diseases

Volumn 41, Issue 3, 2003, Pages 571-579

  McCullough, Peter A ^a   Duc, Philippe ^b   Omland, Torbjørn ^b   McCord, James ^b   Nowak, Richard M ^b   Hollander, Judd E ^b   Herrmann, Howard C ^b   Steg, Philippe G ^b   Westheim, Arne ^b   Knudsen, Cathrine Wold ^b   Storrow, Alan B ^b   Abraham, William T ^b   Lamba, Sumant ^b   Wu, Alan H B ^b   Perez, Alberto ^b   Clopton, Paul ^b   Krishnaswamy, Padma ^b   Kazanegra, Radmila ^b   Maisel, Alan S ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b NONE

Author keywords

B type natriuretic peptide (BNP); Diagnosis; Heart failure; Kidney; Renal insufficiency; Tests

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOFLUORESCENCE TEST; KIDNEY; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; SURVIVAL;

EID: 0037374349     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50118     Document Type: Article

References (30)

1. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD: Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol 39:60-69, 2002
2. Graves EJ: US Department of Health and Human Services, Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1990. Washington, DC, National Center for Health Statistics, Vital and Health Statistics, 1991 (series 13, no. 113, DHHS publ no. 92-1774)
3. Hoes AW, Mosterd A, Grobbee DE: An epidemic of heart failure? Recent evidence from Europe. Eur Heart J 19:SL2-SL9, 1998 (suppl L)
4. Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 22:SA6-SA13, 1993 (suppl A)
5. Zannad F, Braincon S, Juilliere Y, et al: Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: The EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 33:734-742, 1999
6. Meyer KB, Levey AS: Controlling the epidemic of cardiovascular disease in chronic renal disease: Report from the National Kidney Foundation Task Force on cardiovascular disease. J Am Soc Nephrol 9: S31-S42, 1998 (suppl 12)
7. Collins AJ: End-stage renal disease. Are we ready for an emerging epidemic? Postgrad Med 108:13-15, 2000
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
9. Nagagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I: Rapid transcriptional activation and early m RNA turnover of BNP in cardiocyte hypertrophy. Evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96:1280-1287, 1995
10. Maeda K, Takayoshi T, Wada A, Hisanaga T, Kinoshita M: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135:825-832, 1998
11. Harrison A, Morrison LK, Krishnaswamy P, et al: B-Type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39:131-138, 2002
12. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35:681-689, 2000
13. Maisel AS, Krishnaswamy P, Nowak RM, et al: Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure: Primary results from the Breathing Not Properly (BNP) Multinational Study. N Engl J Med 347:161-167, 2002
14. Cheng V, Kazanagra R, Garcia A, et al: A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. J Am Coll Cardiol 37:386-391, 2001
15. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A: Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39:202-209, 2002
16. National Kidney Foundation: Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis 2:S46-S75, 2002 (suppl 1)
17. Cataliotti A, Malatino LS, Jougasaki M, et al: Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 76: 1111-1119, 2001
18. Stein BC, Levin RI: Natriuretic peptides: Physiology therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 135:914-923, 1998
19. Tsutamoto T, Wada A, Maeda K, et al: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96:509-516, 1997
20. Sudoh T, Maekawa K, Kojima M, Minamino N, Kangawa K, Matsuo H: Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 159:1427-1434, 1989
21. Kojima M, Minamino N, Kangawa K, Matsuo H: Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem Biophys Res Commun 159:1420-1426, 1989
22. Luchner A, Stevens TL, Borgeson DD, et al: Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274:H1684-H1689, 1998
23. Pedersen EB, Pedersen HB, Jensen KT: Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans. Clin Sci (Colch) 97:201-206, 1999
24. Parmley WW: Pathophysiology of congestive heart failure. Am J Cardiol 56:7A-11A, 1985
25. Wegner M, Ganten D, Stasch JP: Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats. Hypertens Res 19:229-238, 1996
26. Ozaki J, Shimizu H, Hashimoto Y, Itoh H, Nakao K, Inui K: Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides. Eur J Pharmacol 370:307-312, 1999
27. Totsune K, Takahashi K, Satoh F, et al: Urinary immunoreactive brain natriuretic peptide in patients with renal disease. Regul Pept 63:141-147, 1996.
28. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F: Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 44:S61-S64, 1995 (suppl 1)
29. de Lemos JA, Morrow DA, Bentley JH, et al: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345:1014-1021, 2001
30. McCullough PA, Nowak RM, Foreback C, et al: Emergency evaluation of chest pain in patients with advanced kidney disease. Arch Intern Med 162:2464-2468, 2002